First patients included in large placebo-controlled multicentre study on ColdZyme

Document -

First patients included in large placebo-controlled multicentre study on ColdZyme

  • License: Creative Commons Attribution
    With a Creative Commons license, you keep your copyright but allow people to copy and distribute your work, provided they give you credit. You permit others to copy, distribute, display and perform the work, as well as make derivative works based on it.
  • File format: .pdf
Download

Contacts

Fredrik Lindberg

Press contact CEO +46 (0)708-86 53 70

Related content

First patients included in large placebo-controlled multicentre study on ColdZyme

Enzymatica has initiated a prospective double-blind, placebo-controlled multicentre study to evaluate the effects of ColdZyme® Mouth Spray on the common cold. The study will include 600 patients and is conducted at 10 study centres in Germany. The first patients have now been enrolled in the study, which is expected to be completed during the second half of 2019.

The goal of the study is to